MI Cancer Seek
FDA-approved tissue NGS comprehensive tumor-profiling and companion-diagnostic device within the Caris MI Profile platform.
- Developer
- Caris Life Sciences
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- Copy number, DNA mutation, RNA expression
- Current version
- MI Cancer Seek P240010 current device family (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 4 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.